[The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000601:surgery; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced* / Q000517:prevention & control; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008408:Mastectomy; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications
D000970:Antineoplastic Agents; D016651:Lithium Carbonate; D003520:Cyclophosphamide; D008094:Lithium; D005472:Fluorouracil; D008727:Methotrexate
L'utilizzazione del carbonato di litio in pazienti mastectomizzate sotto trattamento antiblastico.